| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/07/2007 | EP1758857A1 Indole derivatives as antiviral agents |
| 03/07/2007 | EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 03/07/2007 | EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |
| 03/07/2007 | CN1926141A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 03/07/2007 | CN1926132A Pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2007 | CN1926131A Heterocycle grafted monomers and related polymers and hybrid inorganic-organic polymer membranes |
| 03/07/2007 | CN1926130A Bis-indole pyrroles useful as antimicrobials agents |
| 03/07/2007 | CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 03/07/2007 | CN1926104A Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators |
| 03/07/2007 | CN1926103A Sulphonylpyrroles as HDAC inhibitors |
| 03/07/2007 | CN1925859A 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy |
| 03/07/2007 | CN1923832A Novel pyridazinone compound, preparation method and application thereof |
| 03/07/2007 | CN1923820A Novel carboxylic acid derivatives, their preparation and use |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1303073C Substituted triazolone benzyl amine triazole antifungal compounds and method for preparing same |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/06/2007 | US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186827 Dipeptide synthesis |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186746 Indoles having anti-diabetic activity |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
| 03/06/2007 | US7186740 Imidazopyrazines as cyclin dependent kinase inhibitors |
| 03/06/2007 | US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186716 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | CA2200898C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 03/01/2007 | WO2007024944A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 03/01/2007 | WO2007024843A2 Pyrimidinyl-pyrazole inhibitors of aurora kinases |
| 03/01/2007 | WO2007024754A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 03/01/2007 | WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | WO2007024612A2 8-substituted benzoazepines as toll-like receptor modulators |
| 03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
| 03/01/2007 | WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 03/01/2007 | WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors |
| 03/01/2007 | WO2007023073A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 03/01/2007 | WO2007022938A2 Compounds |
| 03/01/2007 | WO2007022934A2 Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors |
| 03/01/2007 | WO2007022933A1 Triazole derivatives as modulators of dopamine d3 receptors |
| 03/01/2007 | WO2007022845A1 Novel materials for organic electroluminescent devices |
| 03/01/2007 | WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/01/2007 | WO2006124748A3 Multicyclic compounds and methods of their use |
| 03/01/2007 | WO2006116157A9 Dipeptidyl peptidase-iv inhibitors |
| 03/01/2007 | WO2006047528A3 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 03/01/2007 | US20070049758 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 03/01/2007 | US20070049757 Methods for the synthesis of substituted amino uracils |
| 03/01/2007 | US20070049751 5-(5-iodo-2-isopropyl-4-methoxy-phenoxy)-pyrimidine-2,4-diamine; using iodine monchloride for iodination, cyanoalkylation, hdyrogenation, cyclization; chemical intermediates; using guanidine carbonate, Brederick's reagent and aniline reagent |
| 03/01/2007 | US20070049688 Method for preparing polymer maleimides |
| 03/01/2007 | US20070049623 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections |
| 03/01/2007 | US20070049622 Substituted benzimidazoles and methods of preparation |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049619 e.g. 3-((S)-2-amino-2-{trans-4-[4-(5-cyano-2-pyridinyl)-1-piperazinyl]-1-cyclohexyl}acetyl)-1,3-thiazolidine; dipeptidyl-peptidases inhibitor; suppress cleavage of glucagon-like peptides (GLP-1) by inhibition of DPP-IV; antidiabetic agent; obesity, non insulin-dependent diabetes |
| 03/01/2007 | US20070049618 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 03/01/2007 | US20070049611 Phosphodiesterase 4 inhibitors |
| 03/01/2007 | US20070049604 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof |
| 03/01/2007 | US20070049592 Bis-aryl urea compounds and methods of use |
| 03/01/2007 | US20070049589 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases |
| 03/01/2007 | US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 03/01/2007 | US20070049581 (R)-2-(1'-carboxymethyl-4,4'-bipiperidinyl-1-yl)-1-(3-chloro-4-hydroxy-5-methyl-benzyl)-2-oxo-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine, headaches, non-insulin-dependent diabetes, irritable bowel syndrome |
| 03/01/2007 | US20070049578 Cinnamamide compounds as metabotropic glutamate receptor antagonists |
| 03/01/2007 | US20070049577 CGRP antagonists |
| 03/01/2007 | US20070049574 4,5-Dicyclopropyl-1-methyl-2-phenyl-1,2-dihydro-pyrazol-3-one; 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1); 4-Cyclopropyl-5-(2,2-difluoro-cyclopropyl)-1-methyl-2-(2-trifluoromethyl-phenyl)-1,2-dihydro-pyrazol-3-one; |
| 03/01/2007 | US20070049571 Dipiperazinyl ketones and related analogues |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049536 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 03/01/2007 | US20070048752 Mass tags for quantitative analyses |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | CA2620173A1 Alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620171A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2619581A1 8-substituted benzoazepines as toll-like receptor modulators |
| 03/01/2007 | CA2619366A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseases |
| 03/01/2007 | CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | CA2619037A1 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 03/01/2007 | CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors |
| 02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 02/28/2007 | EP1757594A1 Quinazoline derivative |
| 02/28/2007 | EP1757591A1 Cinnamide compound |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1756096A1 Indolyl derivatives as liver-x-receptor modulators |
| 02/28/2007 | EP1756094A1 3-cycloalkylbenzazepines as histamine h3 antagonists |
| 02/28/2007 | EP1756093A1 Processes for preparing gonadotropin releasing hormone receptor antagonists |
| 02/28/2007 | EP1756092A1 Novel inhibitors of rho-kinases |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756090A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/28/2007 | EP1756089A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/28/2007 | EP1756087A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 02/28/2007 | EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/28/2007 | EP1756076A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |